Similarly, cells in CF whole blood exposed to multiple toll-like receptor (TLR) agonists mounted less robust inflammatory responses than cells from healthy donors (Kosamo et al., 2019), including decreased secretion of TNF and other NF-κB-induced cytokines. This evidence concerns the gene NFKB1 and cystic fibrosis.